CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I, Two-stage, and Open Label Study to Evaluate the Safety and Tolerability of Using NaviFUS System in Patients With Drug Resistant Epilepsy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03860298
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:56.699341+00:00
Published At: 2020-11-13T00:00:00+00:00
Record Updated At: 2020-11-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Drug Resistant Epilepsy", "Epilepsy, Drug Resistant", "Drug Refractory Epilepsy", "Epilepsy, Drug Refractory", "Intractable Epilepsy", "Epilepsy, Intractable", "Medication Resistant Epilepsy", "Refractory Epilepsy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-11-13"
protocolSection.identificationModule.nctId: "NCT03860298"
protocolSection.identificationModule.officialTitle: "A Phase I, Two-stage, and Open Label Study to Evaluate the Safety and Tolerability of Using NaviFUS System in Patients With Drug Resistant Epilepsy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.